Clinical trial · Interventional
Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients
Effect of Perioperative ERAS Based Nursing Intervention on Hope Level of Patients With Laryngeal Cancer
NCT04174950CI-TRIAL-00041881unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To explore the effect of perioperative ERAS based nursing model on the hope level and recovery of patients with laryngeal cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Laryngeal Cancer | Malignant Laryngeal Neoplasm | CURATED_EXACT | 0.92 |
| Nursing | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Perioperative Enhanced Recovery After Surgery (ERAS) Based Nursing Model | Other | — | UNRESOLVED |
| Routine nursing care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- control group
- description
- Routine perioperative nursing intervention
- interventionNames
- Other: Routine nursing care
- type
- EXPERIMENTAL
- label
- experimental group
- description
- Perioperative ERAS Based Nursing Model
- interventionNames
- Other: Perioperative Enhanced Recovery After Surgery (ERAS) Based Nursing Model
Primary outcomes (2)
- measure
- Hope level
- timeFrame
- the day before surgery
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients were confirmed as laryngeal cancer by CT scan. * Patients were given total or partial laryngectomy. Exclusion Criteria: * Unconscious or psychiatric patients. * Patients with distant metastasis or recurrence of cancer * Patients with coagulation dysfunction * Patients with severe cardiac, hepatic or renal dysfunction.
References
Publications (0)
Data not yet available
No reference posted for this study.